The tirzepatide dose chart follows a different escalation structure that is worth understanding if you are evaluating alternatives
Hwang, J.W., Lee, G.E., Woo, J.H
Medication history: prior GLP-1, GIP, insulin, or sulfonylurea use
Ethical approval All procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of the Shonan Health Innovation Park, iPark Institute Co., Ltd., accredited by AAALAC International, and conducted in accordance with institutional guidelines
Managing the GLP-1 Plateau Some patients find that after several months on a GLP-1 medication, their weight loss stalls even at the maximum dosage